药物信息为reglan tablets (metoclopramide tablets, USP) (Alaven Pharmaceutical LLC): WARNING: TARDIVE DYSKINESIA

Ads
  • Treatment with metoclopramide can cause tardive dyskinesia, a serious movement disorder that is often irreversible. The risk of developing tardive dyskinesia increases with duration of treatment and total cumulative dose.

    Metoclopramide therapy should be discontinued in patients who develop signs or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia. In some patients, symptoms may lessen or resolve after metoclopramide treatment is stopped.

    Treatment with metoclopramide for longer than 12 weeks should be avoided in all but rare cases where therapeutic benefit is thought to outweigh the risk of developing tardive dyskinesia.

    See WARNINGS

  • Drug Information Provided by National Library of Medicine (NLM).
Ads